{
  "url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025/introduction",
  "json_url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025/introduction.json",
  "legislation": "uksi/2025/749",
  "legislation_title": "The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025",
  "legislation_url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025",
  "path": "introduction",
  "kind": "introduction",
  "number": null,
  "heading": "Introductory text",
  "text": "MEDICAL DEVICES\nFEES AND CHARGES\nMade 25th June 2025\nComing into force in accordance with regulation 1(2)\nThe Secretary of State makes these Regulations in exercise of the powers conferred by section 8C(1)(a) and (c) of, and paragraphs 1(1)(ab) and 7(2) of Schedule 4 and paragraph 21 of Schedule 7 to, the European Union (Withdrawal) Act 2018, and sections 15(1), 16(1), 17(1)(a) and 43 of the Medicines and Medical Devices Act 2021.\nThe Secretary of State has carried out a public consultation in accordance with section 45(1) of the Medicines and Medical Devices Act 2021.\nIn accordance with section 15(2) to (4) of the Medicines and Medical Devices Act 2021, the Secretary of State’s overarching objective in making these Regulations is safeguarding public health, and the Secretary of State has had regard to the matters specified in section 15(3) of that Act, and the Secretary of State considers that, where these Regulations may have an impact on the safety of medical devices, the benefits of making these Regulations outweigh the risks.\nIn accordance with section 47(3), (4) and (6)(a) of the Medicines and Medical Devices Act 2021 and paragraphs 8F(1) and (2)(c) and 12(1) of Schedule 7 to the European Union (Withdrawal) Act 2018, a draft of this instrument has been laid before and approved by a resolution of each House of Parliament.\nThe Treasury have consented to the making of these Regulations as required by paragraphs 3(1) and 10 of Schedule 4 to the European Union (Withdrawal) Act 2018.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "The powers in paragraphs 1(1)(ab) and 7(2) of Schedule 4 to the European Union (Withdrawal) Act 2018 are exercisable by the “appropriate authority”. See paragraph 2 of that Schedule, which defines “appropriate authority” for the purposes of paragraph 1 of that Schedule. See also paragraph 8 of that Schedule, which defines “appropriate authority” for the purposes of paragraph 7 of that Schedule."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "2018 c. 16. The European Union (Withdrawal) Act 2018 was amended by the European Union (Withdrawal Agreement) Act 2020 (c. 1) (“the 2020 Act”). Section 8C was inserted by section 21 of the 2020 Act, and paragraph 1(1)(ab) of Schedule 4 by section 28 of the 2020 Act. Paragraph 21 of Schedule 7 was amended by paragraph 53(2) of Schedule 5 to the 2020 Act."
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "2021 c. 3. The Medicines and Medical Devices Act 2021 was amended by the Health and Care Act 2022 (c. 31)."
    },
    {
      "type": "footnote",
      "label": "f4",
      "text": "Paragraph 8F was inserted by paragraph 51 of Schedule 5 to the 2020 Act."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2025/749/introduction",
    "retrieved_at": "2026-10-28T21:14:21.127792+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}